---
figid: PMC5764090__nihms932384f1
figtitle: HiJAKing the Epigenome in Leukemia and Lymphoma
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC5764090
filename: nihms932384f1.jpg
figlink: /pmc/articles/PMC5764090/figure/F1/
number: F1
caption: 'In many types of leukemia, STAT5 and/or STAT3 are constitutively activated
  by JAK2 signaling from receptors of diverse cytokines/growth factors, or directly
  by JAK2V617F, a hallmark of myeloproliferative neoplasms (MPN). In addition to this
  canonical pathway, both JAK2 and JAK2V617F can activate chromatin by phosphorylation
  of tyrosine 41 of the histone H3 (H3Y41) and displacement of the inhibitory protein
  HP1 from chromatin. Target genes in the canonical JAK/STAT pathway, along with those
  through the epigenetic mechanism, are persistently activated in transformed cells
  to promote cell survival and proliferation, as well as to alter differentiation
  programs. GM-CSF: granulocyte-macrophage colony stimulating factor; LIF: leukemia
  inhibitory factor; EPO: erythropoietin; TPO: thrombopoietin.'
papertitle: HiJAKing the Epigenome in Leukemia and Lymphoma.
reftext: Amanda C. Drennan, et al. Leuk Lymphoma. ;58(11):2540-2547.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.958167
figid_alias: PMC5764090__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5764090__F1
ndex: a86ff277-dee4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5764090__nihms932384f1.html
  '@type': Dataset
  description: 'In many types of leukemia, STAT5 and/or STAT3 are constitutively activated
    by JAK2 signaling from receptors of diverse cytokines/growth factors, or directly
    by JAK2V617F, a hallmark of myeloproliferative neoplasms (MPN). In addition to
    this canonical pathway, both JAK2 and JAK2V617F can activate chromatin by phosphorylation
    of tyrosine 41 of the histone H3 (H3Y41) and displacement of the inhibitory protein
    HP1 from chromatin. Target genes in the canonical JAK/STAT pathway, along with
    those through the epigenetic mechanism, are persistently activated in transformed
    cells to promote cell survival and proliferation, as well as to alter differentiation
    programs. GM-CSF: granulocyte-macrophage colony stimulating factor; LIF: leukemia
    inhibitory factor; EPO: erythropoietin; TPO: thrombopoietin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il7
  - Epo
  - Epx
  - Il6
  - Lif
  - Lifr
  - Csf2
  - Il15
  - Tpo
  - Thpo
  - Il3
  - Jak2
  - Stat5a
  - Stat3
  - Cbx5
  - Hp
  - H3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - IL7
  - LINC02605
  - EPO
  - TIMP1
  - EPX
  - IL6
  - LIF
  - IL15
  - TPO
  - THPO
  - IL3
  - CSF2
  - JAK2
  - STAT5A
  - STAT5B
  - STAT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - DEFA1
  - CBX5
  - DEFA1B
---
